The SHAPES strategy: an NMR-based approach for lead generation in drug discovery.

BACKGROUND Recently, it has been shown that nuclear magnetic resonance (NMR) may be used to identify ligands that bind to low molecular weight protein drug targets. Recognizing the utility of NMR as a very sensitive method for detecting binding, we have focused on developing alternative approaches that are applicable to larger molecular weight drug targets and do not require isotopic labeling. RESULTS A new method for lead generation (SHAPES) is described that uses NMR to detect binding of a limited but diverse library of small molecules to a potential drug target. The compound scaffolds are derived from shapes most commonly found in known therapeutic agents. NMR detection of low (microM-mM) affinity binding is achieved using either differential line broadening or transferred NOE (nuclear Overhauser effect) NMR techniques. CONCLUSIONS The SHAPES method for lead generation by NMR is useful for identifying potential lead classes of drugs early in a drug design program, and is easily integrated with other discovery tools such as virtual screening, high-throughput screening and combinatorial chemistry.

[1]  P. Stilbs,et al.  Fourier transform pulsed-gradient spin-echo studies of molecular diffusion , 1987 .

[2]  J M Moore,et al.  Microdrop screening: A rapid method to optimize solvent conditions for NMR spectroscopy of proteins , 1998, Journal of biomolecular NMR.

[3]  Stephen W. Fesik,et al.  One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules , 1997 .

[4]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[5]  M. Shapiro,et al.  NUCLEAR OVERHAUSER EFFECT ON DIFFUSION MEASUREMENTS , 1999 .

[6]  Michael J. Shapiro,et al.  Chemical Exchange in Diffusion NMR Experiments , 1998 .

[7]  P W Kuchel,et al.  Hemoglobin affinity for 2,3-bisphosphoglycerate in solutions and intact erythrocytes: studies using pulsed-field gradient nuclear magnetic resonance and Monte Carlo simulations. , 1994, Biophysical journal.

[8]  G. Bemis,et al.  The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. , 1997, Chemistry & biology.

[9]  C. Dobson,et al.  Pulse methods for the simplification of protein NMR spectra , 1975, FEBS letters.

[10]  R. Andrew Byrd,et al.  ASSOCIATION OF BIOMOLECULAR SYSTEMS VIA PULSED FIELD GRADIENT NMR SELF-DIFFUSION MEASUREMENTS , 1995 .

[11]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[12]  P. Hajduk,et al.  NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. , 1997, Journal of medicinal chemistry.

[13]  E. Guittet,et al.  A New Approach in the Use of Gradients for Size-Resolved 2D-NMR Experiments , 1996 .

[14]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .

[15]  K. Dill,et al.  From Levinthal to pathways to funnels , 1997, Nature Structural Biology.

[16]  Jean M. Severin,et al.  Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR , 1997 .

[17]  B. Meyer,et al.  Screening mixtures for biological activity by NMR. , 1997, European journal of biochemistry.

[18]  G. Wider,et al.  Self-compensating pulsed magnetic-field gradients for short recovery times , 1994 .

[19]  Feng Ni,et al.  Recent developments in transferred NOE methods , 1994 .

[20]  G. Jarori,et al.  Two-dimensional transferred nuclear Overhauser effect spectroscopy (TRNOESY) studies of nucleotide conformations in creatine kinase complexes: effects due to weak nonspecific binding. , 1993, Biochemistry.

[21]  William H. Press,et al.  Numerical recipes in C. The art of scientific computing , 1987 .

[22]  Philip R. Cohen,et al.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.

[23]  A. Bax,et al.  Significant conformational changes in an antigenic carbohydrate epitope upon binding to a monoclonal antibody. , 1990, Biochemistry.